Dr. Lynda K Williamson, D.O. Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 4511 S Glenrose Rd, Spokane, WA 99223 Phone: 509-456-2406 Fax: 509-456-2407 |
Scott Ray Pleines, PA Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 551 E Hawthorne Rd, Spokane, WA 99218 Phone: 509-252-1900 Fax: 509-474-5859 |
Timothy Daniel Dibble, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1123 N Evergreen Rd, Spokane Valley, WA 99216 Phone: 509-363-3100 Fax: 509-363-0300 |
Jaisimha K Iyengar, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1818 S Union Ave, Ste 1a, Tacoma, WA 98405 Phone: 253-627-2666 Fax: 253-627-8661 |
Wesley San, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3315 S 23rd St, Suite 200, Tacoma, WA 98405 Phone: 253-272-9994 Fax: 253-572-0468 |
Kiang Yien A Cheung, MD Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 1628 S Mildred St Ste 102, Tacoma, WA 98465 Phone: 206-538-6300 Fax: 206-538-6301 |
Laurence Brian Ready, MD Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-459-6509 |
Mr. Raymond Zhang, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 Fax: 253-596-3301 |
Dr. Allison Evans Gullo, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 6926 Ne Fourth Plain Blvd, Vancouver, WA 98661 Phone: 360-993-3000 |
Dr. Anthony E Larhs, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 Ne 104th Ave, Ste 106, Vancouver, WA 98664 Phone: 503-246-6666 Fax: 503-246-9465 |
News Archive
Researchers at UT Southwestern Medical Center have defined a key step in the production of beta-amyloid, a short protein that is thought to be responsible for the development of Alzheimer's disease. Understanding this step may aid in the discovery of drugs that could help block the disease from developing.
An experimental therapy being tested by University of Alberta scientists that targets the spinal cord may one day be key to spurring on enhanced recovery for stroke victims.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
A newly discovered genetic variation, in combination with a second variation, reduces the ability of statin drugs to lower "bad" LDL cholesterol, researchers report at the American Heart Association's Scientific Sessions 2005.
› Verified 9 days ago